Platform trial for preterm birth care
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This trial is testing different treatments for pregnant people at risk of early labor or for babies born early. It uses a flexible platform to find the best care for each situation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant and at risk of early labor (before 37 weeks) OR your baby was born early.
- You are being cared for at a hospital that is part of this trial.
- You meet the specific rules for at least one treatment option (called a 'domain') offered at your hospital.
- Your or your baby's health is not immediately critical with death expected soon.
- You (or your baby's parent/guardian) can understand and agree to the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if personalized stress-reduction care during pregnancy can lower the risk of preterm birth, especially for those at higher risk. It is for people with a singleton pregnancy between 8 and nearly 20 weeks who receive care at UNC Chapel Hill.
This study looks at different care pathways to help lower the risk of preterm birth (birth too early). It will follow pregnant people with a singleton pregnancy to see which approaches may work best for preventing early delivery.
This study tests an e-health program to help families of babies born between 28 and 34 weeks. The program provides online tools and guidance, aiming to improve health and development.
This trial tests different antibiotics to prevent infection in pregnancies where the water broke before 37 weeks, as long as labor hasn't started and there's no infection yet. It aims to find the best antibiotic to protect both mother and baby.
This trial tests whether giving caffeine citrate early to very preterm babies (born before 32 weeks) can improve their breathing and overall health. It's for babies who need caffeine anyway as part of their care, and it looks at short- and long-term benefits.
This trial tests a new medicine, CBP-4888, for pregnant women hospitalized with preeclampsia starting after 20 weeks. The goal is to see if it's safe and how it works for you and your baby, who will be followed for up to 24 months after birth.
Hear when a new Preterm Birth trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.